The Campbell’s Company (CPB) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
9 Jul, 2026Opening remarks and agenda
Meeting convened with introductions of board members and executive team, and confirmation of quorum for official proceedings.
Agenda included three management proposals and two shareholder proposals, with voting procedures and Q&A sessions outlined.
Board and executive committee updates
All incumbent directors nominated for re-election participated electronically, with their names listed and information available in the proxy statement.
Inspector of Election and independent auditors were introduced, with auditors available for questions.
Shareholder proposals
Proposal to eliminate supermajority voting requirements was presented, citing prior strong support among outside shareholders but ultimately opposed by the board.
Proposal for a report on regenerative agriculture program effectiveness, including pesticide reduction, was presented, emphasizing transparency and risk mitigation, but opposed by the board as duplicative and potentially counterproductive.
Latest events from The Campbell’s Company
- Transformation plan targets margin recovery, leverage reduction, and brand-focused growth.CPB
Barclays 19th Annual Global Consumer Conference - Earnings and sales fell, dividend was cut, and a major cost savings plan was announced.CPB
Q4 2026 (Q&A) - Earnings and sales fell as inflation persisted; cost savings and dividend cut target debt reduction.CPB
Q4 2026 Prepared Remarks - Sales and earnings fell sharply, leading to a more cautious outlook and accelerated cost savings.CPB
Q2 2026 Prepared remarks - Net sales and earnings declined, but guidance and premium brands remain resilient.CPB
Q3 2026 Prepared remarks - Net sales fell 4% and margins declined, but cost savings and guidance were maintained.CPB
Q3 2026 (Q&A) - Net sales and earnings fell, prompting lower guidance and accelerated cost-saving actions.CPB
Q2 2026 (Q&A) - Sales and earnings declined, but cost savings and new partnerships support reaffirmed guidance.CPB
Q1 2026 - Net sales rose 9% but organic sales and adjusted EPS declined, prompting lower guidance.CPB
Q2 2025